Special Issue: Silicon Valley: Global model or unique anomaly by Social Science Information/SSI – A Sage Publications international journal
Reporter: Aviva Lev-Ari, PhD, RN
Table of Contents
December 2013; 52 (4)
Special Issue: Silicon Valley: Global model
or unique anomaly/Numéro spécial: La
Silicon Valley: Modèle global ou anomalie
singulière
Guest editor: Henry Etzkowitz
Henry Etzkowitz
Silicon Valley at risk? Sustainability of a global innovation icon: An introduction
to the Special Issue
Social Science Information December 2013 52: 515-538,
doi:10.1177/0539018413501946
Doug Henton and Kim Held
The dynamics of Silicon Valley: Creative destruction and the evolution of the
innovation habitat
Social Science Information December 2013 52: 539-557,
doi:10.1177/0539018413497542
James C Williams
From white gold to silicon chips: Hydraulic technology, electric power and
Silicon Valley
Social Science Information December 2013 52: 558-574,
doi:10.1177/0539018413497834
Annika Steiber and Sverker Alänge
The formation and growth of Google: A firm-level triple helix perspective
Social Science Information December 2013 52: 575-604,
doi:10.1177/0539018413497833
Henry Etzkowitz
StartX and the ‘Paradox of Success’: Filling the gap in Stanford’s
entrepreneurial culture
Social Science Information December 2013 52: 605-627,
doi:10.1177/0539018413498833
Steven Casper
New-technology clusters and public policy: Three perspectives
Social Science Information December 2013 52: 628-652,
doi:10.1177/0539018413501236
Helen Lawton Smith, John Glasson, Saverio Romeo, Rupert Waters, and Andrew
Chadwick
Entrepreneurial regions: Evidence from Oxfordshire and Cambridgeshire
Social Science Information December 2013 52: 653-673,
doi:10.1177/0539018413499978
Calls for Papers: Triple Helix: A Journal of University-Industry-Government
Innovation and Entrepreneurship (THJI)
Social Science Information December 2013 52: 674-675,
doi:10.1177/0539018413508639
SOURCE
From: Henry Etzkowitz <h.etzko@googlemail.com>
Date: Fri, 6 Dec 2013 11:04:05 -0800
Subject: Fwd: Dec SSI
Anne Rocha Perazzo
Editor in chief
Social Science Information/SSI
A Sage Publications international journal
http://ssi.sagepub.com/
Managing Editor
Triple Helix: A Journal of
University-Industry-Government Innovation and Entrepreneurship
A SpringerOpen journal
http://www.springer.com/economics/r+%26+d/journal/40604
Scientific Coordinator
European Network of Organizational
& Work Psychologists ‘ENOP’
Skype ID annerochaperazzoRoom 333
190-198 avenue de France
CS n° 71345
75648 PARIS cedex 13
France
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.
A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.